Abstract
There are more than 200 different diseases classed as interstitial lung diseases (ILDs). For epidemiological and practical purposes, ILDs are classified into diseases of known and unknown etiology. The aim of this review is to evaluate our current knowledge about the efficacy and safety of pulmonary rehabilitation (PR) in patients with ILDs. Other issues, such as ILD pathogenesis, prevalence and comorbidity, are also elaborated in the review. Pulmonary rehabilitation is an important part of comprehensive care for patients with ILDs. In comparison to PR for patients with chronic pulmonary obstructive disease (COPD), the number of clinical studies concerning PR for patients with ILDs is small. The majority of trials have been performed in relatively small groups of patients. The principles of PR in this group of patients are the same as for patients with COPD. Exercise-induced desaturation is frequently observed during PR, which is the main source of complications in patients with ILDs. Major differences between ILD and COPD patients include poorer exercise tolerance and faster development of respiratory failure in patients with ILDs.
Highlights
The aim of this review is to evaluate our current knowledge about the efficacy and safety of pulmonary rehabilitation (PR) in patients with interstitial lung diseases (ILDs)
Pulmonary rehabilitation is an important part of comprehensive care for patients with ILDs
Exercise-induced desaturation is frequently observed during PR, which is the main source of complications in patients with ILDs
Summary
25% of patients with ILDs, especially in the group with severe dyspnea, sleep disorders, markedly reduced FVC and many associated conditions, is related to a progressive reduction in physical activity.[29] Depression is an independent risk factor, and regular screening for its occurrence is recommended.[30]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have